Seelos Therapeutics, Inc. Proceeds from Convertible Debt
Seelos Therapeutics, Inc. reported Proceeds from Convertible Debt of $20.20 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2022-03-04
- Seelos Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2010-12-31 was $2.29M.
- Seelos Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2010-09-30 was $0.00.
- Seelos Therapeutics, Inc. proceeds from convertible debt for fiscal 2021 was $20.20M, a 85.23% increase from fiscal 2020.
- Seelos Therapeutics, Inc. proceeds from convertible debt for fiscal 2020 was $10.91M.
- Seelos Therapeutics, Inc. proceeds from convertible debt for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Seelos Therapeutics, Inc. proceeds from convertible debt for fiscal 2018 was $1.36M.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month | Proceeds from Convertible Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | $20.20M 10-K · filed 2022-03-04 | ||||
| 2020-12-31 | $10.91M 10-K · filed 2022-03-04 | ||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-11 | ||||
| 2018-12-31 | $1.36M 10-K · filed 2020-03-17 | ||||
| 2014-12-31 | $0.00 10-K · filed 2015-03-16 | ||||
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 | ||||
| 2012-12-31 | $3.41M 10-K · filed 2015-03-16 | ||||
| 2011-12-31 | $0.00 10-K · filed 2014-03-17 | ||||
| 2010-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $2.29M derived: sum of 2 quarters · filed 2013-03-18 | $6.19M 10-K · filed 2013-03-18 | $3.89M 10-K · filed 2012-03-13 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $3.90M 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | $3.90M 10-Q · filed 2011-08-15 | ||||
| 2009-12-31 | $686.68K 10-K · filed 2012-03-13 |